[1]华逢春,管一晖,赵军.18F-氟代脱氧葡萄糖PET及PET-CT在淋巴瘤中的临床应用[J].国际放射医学核医学杂志,2005,29(5):216-219,226.
　HUA Feng-chun,GUAN Yi-hui,ZHAO Jun.18F-FDG PET and PET-CT imaging in lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(5):216-219,226.
点击复制

18F-氟代脱氧葡萄糖PET及PET-CT在淋巴瘤中的临床应用(/HTML)
分享到：

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
29
期数:
2005年第5期
页码:
216-219,226
栏目:
PET-CT技术
出版日期:
1900-01-01

文章信息/Info

Title:
18F-FDG PET and PET-CT imaging in lymphoma
作者:
华逢春;  管一晖;  赵军
200235 上海, 复旦大学附属华山医院PET中心
Author(s):
HUA Feng-chun;  GUAN Yi-hui;  ZHAO Jun
PET Center, Huashan Hospital Fudan University, Shanghai 200235, China
关键词:
正电子发射体层显像; 计算机体层成像; 18F-氟代脱氧葡萄糖; 淋巴瘤
Keywords:
positron emission tomography; computed tomography; 18F-fluorodeoxyglucose; lymphoma
分类号:
R814.42;R817.4
摘要:
PET在淋巴瘤的分期、再分期、疗效评价及预后判断中具有重要价值,PET-CT则集中了PET的功能显像与CT的解剖显像的双重优势,对淋巴瘤病灶的定位、定性诊断的准确性更高。
Abstract:
PET imaging plays an important role in staging, restaging, evaluating the treatment effects and the prognosis of the lymphoma. PET-CT realized the fuse of functional and anatomic imaging in one gantry and showed more values in clinical diagnosis. It makes the location and characterization of the lesions more accurate.

参考文献/References:

1 Hoh CK, Glaspy J, Rosen P, et al. Whole-body 18F-FDG PET imagin g for staging of Hodgkin’s disease and lymphoma[J]. J Nucl Med, 1997, 38(3):343-348.
2 Schöder H, Meta J, Yap C, et al. Effect of whole-body 18F-FDG PET imaging on clinical staging and management of patients with malignant lymphoma[J]. J Nucl Med, 2001, 42(8):1139-1143.
3 Schaefer NG, Hany TF, Taverna C, et al. Non-Hodgkin lymphoma and Hodgkin disease:coregistered FDG PET and CT at staging and restaging-do we need contrast-enhanced CT?[J]. Radiology, 2004, 232(3):823-829.
4 Carr R, Barrington SF, Madan B, et al. Detection of lymphoma in bone marrow by whole-body positron emission tomography[J]. Blood, 1998, 91(9):3340-3346.
5 Moog F, Bangerter M, Kotzerks J, et al. 18F-fluorodeoxyglucose positron emission tomography as a new approach to detect lymphomatous bone marrow[J]. J Clin Oncol, 1998, 16(2):603-609.
6 Romer W, Hanauske AR, Ziegler S, et al. Positron emission tomography in non-Hodgkin’s lymphoma:assessment of chemotherapy with fluorodeoxyglucose[J]. Blood, 1998, 91(12):4464-4471.
7 Mikhaeel NG, Timothy AR, O’Doherty MJ, et al. 18F-FDG PET as a prognostic indicator in the treatment of aggressive non-Hodgkins lym phoma:comparison with CT[J]. Leuk Lymphoma,2000, 39(5-6):543-553.
8 Jerusalem G, Beguin Y, Fassotte MF, et al. Persistent tumor 18F-FDG uptake after a few cycles of polychemotherapy is predictive of treatment failure in non-Hodgkin’s lymphoma[J]. Haematologica, 2000, 85(6):613-618.
9 Spaepen K, Stroobants S, Dupont P, et al. Prognostic value of positron emission tomography with Fluorine-18 Fluorodeoxyglucose([18F]-FDG) after first-line chemotherapy in non-Hodgkin’s lymphoma:[18F]FDG-PET a valid alternative to conventional diagnostic methods?[J]. J Clin Oncol, 2001, 19(2):414-419.
10 Weihrauch MR, Re D, Scheidhauer K, et al. Thoracic positron emission tomography using 18F-fluorodeoxyglucose for the evaluation of residual mediastinal Hodgkin disease[J]. Blood, 2001, 98(10):2930-2934.
11 Kostakoglu L, Coleman M, Leonard JP, et al. PET predicts prognosis after one cycle of chemotherapy in aggressive lymphoma and Hodgkin’s disease[J]. J Nucl Med, 2002, 43(8):1018-1027.
12 Freudenberg LS, Antoch G, Schutt P, et al. FDG PET-CT in restaging of patients with lymphoma[J]. Eur J Nucl Med Mol Imaging, 2004, 31(3):325-329.
13 Allen-Auerbach M, Quon A, Weber WA, et al. Comparison between 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography and positron emission tomography/computed tomography hardware fusion for staging of patients with lymphoma[J]. Mol Imaging Biol, 2004, 6(6):411-416.
14 Hoffmann M. 18F-fluorodeoxyglucose positron emission tomography(18F-FDG PET) for assessment of enteropathy-type T cell lymphoma[J]. Gut, 2003, 52(1):347-351.
15 Castellucci P, Zinzani P, Pourdehnad M, et al. (18)F-FDG PET in malignant lymphoma:significance ofpositive findings[J]. Eur J Nucl Med MolImaging, 2005,32(7):749-756.

相似文献/References:

[1]孟德刚,孙晓光,黄钢.SPECT-CT在临床肿瘤学中的应用[J].国际放射医学核医学杂志,2009,33(4):214.[doi:10.3760/cma.j.issn.1673-4114.2009.04.007]
　MENG De-gang,SUN Xiao-guang,HUANG Gang.The applications of SPECT-CT in clinical oncology[J].International Journal of Radiation Medicine and Nuclear Medicine,2009,33(5):214.[doi:10.3760/cma.j.issn.1673-4114.2009.04.007]
[2]左传涛.脑中风患者脑功能重塑研究中应注意的问题[J].国际放射医学核医学杂志,2005,29(1):1.
　ZUO Chuan-tao.The issues in the study of brain plasticity after stroke[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(5):1.
[3]蔡莉,李彦生.氟代脱氧葡萄糖与氨基酸PET在脑肿瘤中的对比研究[J].国际放射医学核医学杂志,2005,29(1):10.
　CAI Li,LI Yan-sheng.Comparison of 18F-FDG and amino acid PET imaging in brain tumors[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(5):10.
[4]董爱生,田建明.部分癫痫的神经影像学诊断[J].国际放射医学核医学杂志,2005,29(4):148.
　DONG Ai-sheng,TIAN Jian-ming.Neuroimaging in the diagnosis of partial epilepsy[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(5):148.
[5]王明芳,罗志福.肿瘤增殖显像剂3’-脱氧-3’-18F-氟代胸苷[J].国际放射医学核医学杂志,2005,29(5):227.
　WANG Ming-fang,LUO Zhi-fu.The current status of 18F-FLT as a proliferation tracer[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(5):227.
[6]盛晓芳,管一晖,赵军,等.PET-CT在脑胶质瘤放射治疗靶区确定中的应用[J].国际放射医学核医学杂志,2005,29(6):241.
　SHENG Xiao-fang,GUAN Yi-hui,ZHAO Jun,et al.Application of PET-CT in delineation of radiotherapy planning target volume for glioma[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(5):241.
[7]董爱生,田建明.PET、SPECT及MRS在帕金森病诊断中的应用[J].国际放射医学核医学杂志,2005,29(6):244.
　DONG Ai-sheng,TIAN Jian-ming.The application of PET、SPECT and MRS in Parkinson’s disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(5):244.
[8]董爱生.18F-FDG PET在结直肠癌中的临床应用价值[J].国际放射医学核医学杂志,2004,28(1):12.
　DONG Ai-sheng.The applications of 18F-FDG PET in colorectal carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2004,28(5):12.
[9]王峰.18F-FDG PET对原发性食管癌和复发性食管癌的诊断价值[J].国际放射医学核医学杂志,2004,28(1):15.
　WANG Feng.The value of 18F-FDG PET in the staging of paimary and recurent esophageal cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2004,28(5):15.
[10]尹立杰.双时相18F-FDG PET在肿瘤良恶性鉴别诊断中的应用[J].国际放射医学核医学杂志,2004,28(2):53.
　YIN Li-jie.Application of dual time point 18F-FDG PET imaging in differentiating malignant from inflammatory lesions[J].International Journal of Radiation Medicine and Nuclear Medicine,2004,28(5):53.
[11]季仲友.PET-CT中诊断性CT的必要性与临床应用[J].国际放射医学核医学杂志,2005,29(5):197.
　JI Zhong-you.Necessity and clinical application of diagnostic CT in PET-CT scanner[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(5):197.
[12]陈香,赵军,管一晖.PET-CT常见伪影[J].国际放射医学核医学杂志,2005,29(5):201.
　CHEN Xiang,ZHAO Jun,GUAN Yi-hui.Common artifacts on PET-CT images[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(5):201.
[13]吴湖炳.18F-氟代脱氧葡萄糖PET-CT在头颈部肿瘤中的应用价值[J].国际放射医学核医学杂志,2005,29(5):205.
　WU Hu-bing.The clinical application value of 18F-FDG PET-CT on the head and neck cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(5):205.
[14]董孟杰,林祥通,赵军.PET-CT在卵巢癌中的临床应用价值[J].国际放射医学核医学杂志,2005,29(5):209.
　DONG Meng-jie,LIN Xiang-tong,ZHAO Jun.The application of PET-CT in ovarian cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(5):209.
[15]刘建军,黄钢.18F-氟代脱氧葡萄糖PET和PET-CT在转移性骨肿瘤中的应用研究[J].国际放射医学核医学杂志,2005,29(5):213.
　LIU Jian-jun,HUANG Gang.Application study of 18F-FDG PET and PET-CT on malignant bone metastases[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(5):213.
[16]黎海涛.PET-CT在乳腺癌诊断中的应用价值[J].国际放射医学核医学杂志,2005,29(5):220.
　LI Hai-tao.The application value of PET-CT in the diagnosis of breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(5):220.
[17]司宏伟,耿建华,陈盛祖.PET-CT在调强适形放疗中的临床应用[J].国际放射医学核医学杂志,2005,29(5):223.
　SI Hong-wei,GENG Jian-hua,CHEN Sheng-zu.Clinical application of PET-CT in intensive modulated radiotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(5):223.
[18]张锦明,田嘉禾.11C标记的放射性药物在PET-CT肿瘤诊断上的应用[J].国际放射医学核医学杂志,2005,29(5):232.
　ZHANG Jin-ming,TIAN Jia-he.Application of carbon-11 radiopharmaceuticals in PET-CT for tumors[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(5):232.
[19]王利伟,王自正,顾建平,等.孤立性肺结节的影像学研究进展[J].国际放射医学核医学杂志,2005,29(6):248.
　WANG Li-wei,WANG Zi-zheng,GU Jian-ping,et al.The development in imaging of the solitary pulmonary nodules[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(5):248.

备注/Memo

备注/Memo:
收稿日期:2005-07-04。
更新日期/Last Update: 1900-01-01